Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_4446_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
30.08.2026
Размер:
49 Мб
Скачать
33 Pitfalls andPearls inEndoscopic Sinus Surgery
369
33.4.6 Frontal Sinus (Figs.33.11 and33.12)
The frontal recess dissection is always a challenge to the surgeon [79] and it is considered as an advanced step in sinus surgery. In order to achieve the best outcome and avoid injury to the vital structures in the region “orbit and skull base” the surgeon has to be familiar with the frontal recess anatomical variation. Recurrence of diseases in the frontal sinus maybe due to either iatrogenic
Fig. 33.11 CT scan of paranasal sinuses showing the
frontal sinus (FS)
injury of the delicate frontal sinus pathway or incomplete excentration of the disease itself. The frontal recess is an hourglass shape pathway bounded anteriorly by posterior wall of agger nasi, posteriorly by bulla ethmoidalis, medially by middle turbinate, and laterally by lamina papyra­cea. Before starting the dissection of frontal recess, certain point should be accomplished which is to keep a well-mucosalized frontal recess to avoid postoperative scarring and neoosteogen­esis. Angled instruments (like Hosemann, giraffe, Bachert, and mushroom forceps) and endoscopes are essential to success the surgery.
Frontal sinus surgery can be classied accord­ing to Wolfgang Draf’s into:
draf 1: It comprises of anterior ethmoidec­tomy without touching the natural ostium.
draf 2a: It is also called uncapping the egg. It comprises of removal of all ethmoidal cells that encroach the frontal recess like agger nasal and the other fronto-ethmoidal cells between the lamina papyracea laterally and middle turbinate medially.
draf 2b: It comprises of removal of the frontal sinus oor between the lamina papyracea and nasal septum.
draf 3: It comprises of drainage of both side through removal of the oor of frontal sinus from orbit to orbit with removal of part of the upper nasal septum (modied Lothrop procedure).
Fig. 33.12 Endoscopic picture after dissecting the fron-
tal recess and the appearance of frontal sinus (FS)
Choosing between these depends on the
degree of disease extension. Approaching frontal recess can be done either after completing unci­nectomy, MMA, (anterior and posterior) eth­moidectomy and sphenoidotomy or from the rst remove the uncinate and identify the recess, then complete the remaining dissection. In the rst approach, the aim is to identify the skull base at the level of sphenoid sinus, then follow it in post- ant direction till nding the anterior eth­moidal artery; this is done by using angled tele­scope (70° scope is highly useful in this step). An important landmark to locate the artery is the area of attachment of middle turbinate lamina to the skull base once the anterior ethmoidal artery
370
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
O. M. Bargas and A. AbuAlsoud
identied the frontal recess is immediately ante­rior to it, then an angled probe (Bolger–Kuhn probe) is passed to the posterior frontal recess and start fracturing the posterior wall of the agger nasi cell and the other frontal recess cells in antero-inferior direction. Removal of the bony fragment and the mucosal pieces is better done by using through- cutting forceps and microde­brider rather than using standard punch forceps to avoid stripping of the mucosa. The movement of the instrument in the region of the frontal recess should be careful movement; it is better to move from posterior to anterior direction (to avoid the anterior ethmoidal artery, the skull base and due to the presence of the beak which is a thick bone anteriorly) and from medial to lat­eral direction (to be away from the lateral lamella). The other approach to the frontal recess is through what is called intact bulla technique in which the uncinate process is removed and start removing the agger nasi by passing above the bulla medial to middle turbinate. Once the agger posterior wall is removed, the anterior ethmoidal artery is identied and hence the skull base then the dissection continues the rest dissection. Another method of intact bulla technique is like what Wormald use in which a mucosal ap is elevated just anterior to the middle turbinate axilla and reected posteriorly, then dissect the anterior wall of the agger nasi [10] to discover the frontal recess.
Various types of frontal cells are present which is best described in modied Kuhn classica­tion as following:
• Type 1—Single cell above the agger nasi cell.
• Type 2—Tier of cells above agger nasi cell.
• Type 3—Single large cell extending to <50% of the vertical height of the frontal sinus.
• Type 4—Large cell extending to >50% of the vertical height of the frontal sinus or isolated cell within the sinus.
All these types of frontal cells should be removed
in the same manner of removing agger nasi cell.
Other types of frontoethmoidal cells include:
• Suprabullar cells which present above the bulla and extend to skull base and may com­press the frontal recess from behind.
• Supraorbital cell extends above the orbit and opens behind the frontal recess and anterior to anterior ethmoidal artery.
• interfrontal sinus septal cell a pneumatization of the interfrontal sinus septum with variable extension which may compress the frontal recess from medial to lateral.
These cells should be well studied on CT scan
before working on the frontal sinus as it may require special instrument or even require com­bined approach to completely manage the dis­ease and open the frontal recess correctly. Emerging of the navigation system in the endo­scopic sinus surgery plays an important role in revision cases and in presence of anatomical variation especially in frontal recess region to avoid injury to the nearby vital structure and to achieve complete clearness of the recess.
Pitfall and Pearls of Frontal Sinus Surgery
• Endoscopic approach to frontal recess is
the golden way to treat chronic frontal sinusitis.
• Good knowledge of the normal anatomy
and the normal anatomical variation is vital for surgery success.
• Do the best in maintaining the mucosal
lining of the frontal recess.
• Try to avoid middle meatal collapse
postoperatively by maintaining middle turbinate attachment, use of middle meatal spacer, or even bolgerization.
• Postoperative care is crucial in endo-
scopic fontal surgery to maintain the function and avoid closure of the recess by blood clots and crust.
• CT scan coronal and sagittal cuts are nec-
essary to study the frontal recess region.
AL GRAWANY
33 Pitfalls andPearls inEndoscopic Sinus Surgery
Take Home Messages
If you can’t help don’t
Respect the tissues as
much as possible
371
harm
Don’t forget the aim of
FESS (remove the
disease and provide way
for topical medications)
Good preoperative
imaging study is vital
References
1. Wormald PJ, McDonogh M.The ‘swing-door’ tech­nique for uncinectomy in endoscopic sinus surgery. J Laryngol Otol. 1998;112(6):547–51.
2. Wormald P-J. Endoscopic sinus surgery, vol. 5. Stuttgart: Thieme; 2013. p.28–44.
3. Stammberger H.Endoscopic surgery for mycotic and chronic recurring sinusitis. Ann Otol Rhinol Laryngol. 1985;94(5_Suppl):1–11.
4. Yanagisawa E, Joe JK, Christmas DA. Where is the ostium of the ethmoid bulla? Ear Nose Throat J. 1999;78(12):886.
5. Schlosser RJ, Harvey RJ. Endoscopic sinus surgery: optimizing outcomes and avoiding failures. San Diego: Plural Publishing; 2012.
follow the learning
curve of ESS
6. Kim H, Kim S, Kang SS, Chung IH, Lee J, Yoon J.Surgical anatomy of the natural ostium of the sphe­noid sinus. Laryngoscope. 2001;111(9):1599–602.
7. Levine HL. Endoscopic sinus surgery: reasons for failure. Oper Tech Otolaryngol Neck Surg. 1995;6(3):176–9.
8. Kennedy DW, Senior BA. Endoscopic sinus sur­gery. A review. Otolaryngol Clin North Am. 1997;30(3):313–30.
9. Stammberger H, Kopp W, Dekornfeld TJ. Special endoscopic anatomy. In: Functional Endoscopic Sinus Surgery: The Messerklinger Technique. Philadelphia: Decker Publication; 1991. p.61–90.
10. May M, Schaitkin B.Frontal sinus surgery: endonasal drainage instead of an external osteoplastic approach. Oper Tech Otolaryngol Neck Surg. 1995;6(3):184–92.
Part IV
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
Head and Neck
AL GRAWANY
Thyroid andParathyroid Glands
HassanHaidar, AbdelrahmanAlsaleh, WaheedRahman, andHusseinEnezi
34
34.1 Introduction
Thyroid gland comprises two types of cells: fol­licular cells (or thyrocytes) which produce and secrete thyroglobulin and thyroid hormones, and parafollicular cells (or C cells), which secrete calcitonin. Papillary Thyroid Carcinoma (PTC) and Follicular Thyroid Carcinoma (FTC) are tumors originating by thyrocytes and are referred as Differentiated Thyroid Carcinomas (DTCs). Anaplastic Thyroid Carcinoma (ATC) is the undifferentiated tumor which may arise from DTCs or may be undifferentiated to origin. Medullary Thyroid Carcinoma (MTC) is the tumor arising to C cell.
The four parathyroid glands, located posterior to the thyroid gland, regulate calcium homeosta­sis through release of parathyroid hormone (PTH). PTH increases serum calcium levels through direct action on bone and the kidneys. It stimulates osteoclasts to resorb bone and mobi­lize calcium into the blood.
34.2 Thyroid Gland
34.2.1 Embryology
The thyroid gland develops from three pharyn­geal bodies: the median anlage and two lateral bodies. Median anlage is derived as a ventral diverticulum at the foramen cecum. During the fourth to seventh week of gestation, the primitive thyroid tissue descends along the thyroglossal duct anterior to the hyoid bone and the laryngeal cartilages to reach its nal position at the level of the second and fourth tracheal rings [1, 2].
Calcitonin-secreting parafollicular C cells arise within the ultimobranchial bodies from neural crest cells of the fourth pharyngeal pouch [3, 4].
The entire gland may lie close to its point of origin at the foramen cecum, giving rise to a lin­gual thyroid. About 70% of patients with lingual thyroid glands have no thyroid tissue in the neck. In many cases, the lingual thyroid does not func­tion normally [3, 4].
The thyroglossal duct ultimately atrophies, but any portion of it may persist to become the site of a thyroglossal duct cyst.
H. Haidar (*) Hamad Medical Corporation, Doha, Qatar
A. Alsaleh · W. Rahman · H. Enezi ENT Department, Hamad Medical Corporation, Doha, Qatar e-mail: wrahman@hamad.qa; halenazi@hamad.qa
© Springer Nature Switzerland AG 2021 A. Al-Qahtani et al. (eds.), Textbook of Clinical Otolaryngology,
https://doi.org/10.1007/978-3-030-54088-3_34
34.2.2 Anatomy oftheThyroid Gland
The gland lies anterior to the second, third, and fourth tracheal rings. Posterolaterally, the gland overlaps the carotid sheath and its contents.
375
376
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
H. Haidar et al.
A pyramidal lobe may be present in about
50% of patients [3, 4].
Arterial blood supply is derived from two
pairs of arteries.
1. The superior thyroid artery: the rst branch of the external carotid artery.
2. The inferior thyroid artery: a branch of the thyrocervical trunk of the subclavian artery. It courses behind the common carotid artery to enter the inferior thyroid pole.
3. The thyroid ima artery: inconsistently present (7%). Because of its relation to the anterior aspect of the trachea, the thyroid ima artery is in danger of injury during a tracheotomy.
34.2.2.1 Lymphatic Drainage
oftheThyroid Gland
Dominant drainage to level VI known as precri­coid, Delphian, paratracheal lymph node.
Anatomy oftheRecurrent Laryngeal Nerve
The right recurrent laryngeal nerve arises from the vagus as this nerve crosses anterior to the right subclavian artery. It then loops around the artery and ascends in the tracheoesophageal groove, posterior to the thyroid gland, to enter the larynx behind the cricothyroid articulation [5].
The nerve on the left arises from the vagus
where it crosses the arch of aorta. It then loops around the aorta to ascend in the tracheoesopha­geal. The left recurrent nerve is generally more closely applied to the trachea in the lower part of its ascending course than is the right nerve.
As the recurrent laryngeal nerves ascend toward
the middle of the thyroid gland, they are intimately associated with the inferior thyroid artery [5, 6].
Classically, the recurrent laryngeal nerve is
found intraoperatively in Simon’s triangle, which is formed by the common carotid artery laterally, the esophagus medially, and the inferior thyroid artery superiorly. The nerve can also be reliably found where it enters the larynx just behind the inferior cornu of the thyroid cartilage.
Anatomy oftheSuperior Laryngeal Nerve
The superior laryngeal nerve originates at the inferior ganglion of the vagus nerve near the jug­ular foramen.
It has two branches; the internal branch pierces the thyrohyoid membrane and supplies sensation to the supraglottic and pyriform sinus [7] and the external branch which supplies the cricothyroid muscle.
The nerve is variable in its relationship to the highest point of the superior pole of the thyroid gland and is at risk of injury during thyroid sur­gery [8].
34.2.3 Benign Thyroid Disease
34.2.3.1 Graves’ Disease
Pathophysiology: Autoimmune, TSH receptor
antibody stimulation goiter and elevated
levels of T3 and T4 secretion [9]. Associated
with exophthalmos and dermatopathy.
Risk factors: exposure to radiation, females
more than males (adolescence or 30–40) and
genetic predisposition.
Histopathology: Shows scattered lymphocytic
inltration.
Investigations: Thyroid-stimulating immuno-
globulin levels (TSIs); Iodine-123 (I123)
scanning shows a diffuse increased gland
uptake [10].
Radioactive Iodine (131I): the most common
therapy used.
Subtotal Thyroidectomy: indicated when med-
ical therapy fails [11].
Exophthalmos and optic neuropathy If
optic neuropathy persists despite medical therapy, corticosteroids for 2 weeks; if no improvement, then surgical decompression is needed which includes trans-nasal endo­scopic approaches to the medial and infe­rior orbital wall [12].
34.2.3.2 Toxic Nodular Goiter
No eye or skin ndings as in Graves’ disease.
Evolution of hyperfunctional regions, which results in excess thyroid hormone that causes the suppression of TSH resulting in the adjoining normal gland becoming less active on I123 scans, with hyperfunctional areas being hot [13].
Hyperthyroidism typically does not occur, until the nodule is 3cm or larger or multiple toxic nodules.
AL GRAWANY
34 Thyroid andParathyroid Glands
377
Treatment is either surgery or radioactive iodine, antithyroid medications might be consid­ered prior to more denitive surgical or radio ablative treatment.
34.2.3.3 Hashimoto’s Thyroiditis
Physiopathology: Antithyroglobulin antibody
chronic lymphocytic inammation
Transient hyperthyroidism followed by
hypothyroidism [14].
Risk factors: More common in females in
third to fth decade, genetic susceptibility
(HLA- DR3). Can be associated with lym-
phoma, neoplasms, or other autoimmune dis-
ease such as SLE, Sjogren syndrome, and
scleroderma.
Histopathology: Lymphocytic inltration with
germinal center formation.
Investigations: Antithyroid peroxidase (anti-
TPO) [15].
Treatment: thyroxin therapy; surgical excision
for compressive symptoms or suspicious
nodule.
Complications: Rarely, progress into thyroid
lymphoma. A rapidly enlarging mass within a
Hashimoto’s gland should always raise con-
cern regarding lymphoma and warrants FNA
or biopsy.
34.2.3.4 Subacute Granulomatous
(De Quervain’s) Thyroiditis
Typically, presents as enlarged, painful thyroid, after upper respiratory tract infection, fever and malaise are also common. Half of patients may show hyperthyroidism, then patients will enter a several-month hypothyroid period. Eventually, most patients return to euthyroidism.
I123 scanning usually shows less than 2% uptake.
It is a self-limiting disease that can be treated with anti-inammatory drugs and rarely steroids [16].
34.2.3.5 Riedel’s Thyroiditis
Fibrosis of thyroid gland of unknown cause that manifests as “rock-hard” thyroid produces local pressure and hypothyroidism. Histologically, it is characterized by widespread brotic process.
34.2.4 Thyroid Nodules
– The prevalence of palpable nodules is only
4–7% while high resolution ultrasound can detect 19–68% of individuals selected ran­domly with higher frequencies in women and the elderly [17].
– Only 5–10% of nodules being malignant [18].
A single dominant or solitary nodule is more likely to represent carcinoma than a single nodule within a multinodular gland, with an incidence of malignancy from 2.7 to 30% and
1.4 to 10%, respectively [19, 20].
– Important elements in patients’ history that
increase the likelihood of malignancy include prior head and neck irradiation, reports of rapid growth, dysphagia, dysphonia, male gender, and presentation at extremes of age.
– Physical examination ndings that increase
the concern for malignancy include: nodules larger than 4cm in size (19.3% risk of malig­nancy), rmness, xation to adjacent tissues, cervical lymphadenopathy. Vocal cord immo­bility [21].
– Ultrasound imaging studies and FNA are the
main tools used to decide whether surgical excision of a thyroid nodule is warranted.
– Molecular genetic biomarker analyses are
now being used to increase the accuracy of FNAB.
34.2.4.1 Ultrasonography
Solid appearance (or hypoechogenicity); increased vascularity; microcalcications; irreg­ular margins; and the absence of a halo are fea­tures that have been consistently associated with malignancy (Table34.1).
34.2.4.2 Radioisotope Imaging
About 80–85% of thyroid nodules are cold and about 10% of these nodules represent a malig­nancy. While hot nodules account for 5% of all nodules and the likelihood of malignancy is less than 1% for these nodules.
Except for obviating the need to perform an FNAB on a hyperfunctioning nodule in patients who are thyrotoxic, the use of radioisotope scan­ning has been abandoned.
378
H. Haidar et al.
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
Table 34.1 The sensitivity and specicity of various
sonographic characteristics
Sonographic characteristic
Sensitivity (%)
Specicity
(%) Microclassications 52 83 Absence of halo 66 54 Irregular margins 55 79 Hypoechoic 81 53 Increased intranodular ow 67 81
Data from Fish SA, Langer JE, Mandel SJ.Sonographic imaging of thyroid nodules & cervical lymph nodes. Endocrinol Metab Clin North Am 2008;37(2):401–17
34.2.4.3 Fine Needle Aspiration Cytology
• Nodules 1 cm or larger or sonographically
suspicious sub-centimeter nodules warrant cytologic analysis through FNAB to deter­mine the risk for malignancy [2224].
The pathology report from FNAB may be read as
benign, malignant, indeterminate, or nondiagnostic.
The only malignant pathology reliably diag­nosed through FNA is papillary thyroid carci­noma because features, such as Orphan Annie nuclei, nuclear grooves, intranuclear inclusions,
and psammoma bodies, can be sufcient for a diagnosis.
Medullary carcinoma, anaplastic carcinoma, lymphoma, poorly differentiated carcinoma, and metastatic disease can also be classied on the basis of cytology.
Benign and malignant follicular neoplasms and oncocytic adenomas and carcinomas cannot be distinguished on the basis of cytology alone, because tissue architecture is required to make the diagnosis of malignancy through observation of capsular or angiolymphatic invasion. Patients with lesions classied as follicular or oncocytic neoplasm, or suspicious for malignancy should be offered a diagnostic lobectomy.
FNAB specimens read as unsatisfactory should be sent for a repeat biopsy while samples read as follicular lesions with unknown signi­cance or “FLUS”. FLUS are generally sent for repeat FNAB, as the risk for malignancy is only 5–10%. FNA that showed follicular neoplasm or suspicious for follicular neoplasm has a 15–30% risk of malignancy and diagnostic thyroidectomy should be discussed with the patient vs. radio­logical surveillance (see algorithm).
High Suspicion
Pattern
Nondiagnostic
Repeat FNA
FNA 1 cm
Benign
No Surgery
Intermediate
Suspicion
Pattern
AUS/FLUS
Suspected thyroid nodule
TSH normal or elevated
Thyroid/Neck US
Low Suspicion
Pattern
FNA 1.5 cm
Cytopathology
Bethesda
system
FN/FSN
Radiological surveillance
or diagnostic surgery
Very Low
Suspicion
Pattern
FNA 2 cm
Suspicious
No nodule or nodule not
meeting FNA size cutoff
Benign Pattern
FNA Not required
Malignant
Surgery
AL GRAWANY
34 Thyroid andParathyroid Glands
379
AUS/FLUS: Atypia of undetermined signi-
cance or follicular lesion of undetermined.
FN/FSN: Follicular neoplasm or suspicious
for a follicular neoplasm [25].
34.2.5 Malignant Thyroid Disease
34.2.5.1 Papillary Thyroid Carcinoma
The most common type of thyroid cancer repre­sents 75–85% of all thyroid cancer cases. More frequently in women and presents in the 20–55 years of age [26].
Features include:
• Characteristics: Orphan Annie eye nucleus and psammoma bodies on light microscopy.
• Lymphatic spread is more common than
hematogenous spread.
• Multifocality is common.
• The so-called “Lateral Aberrant Thyroid” is actually a lymph node metastasis from papil­lary thyroid carcinoma.
• Papillary microcarcinoma is a subset of papil­lary thyroid cancer dened as measuring less than or equal to 1 cm and the management strategies for incidental papillary microcarci­noma on ultrasound (and conrmed on FNAB) range from total thyroidectomy with radioac­tive iodine ablation to observation alone.
Staging (AJCC staging)
T1: 2 cm tumor conned to thyroid (T1a1cm tumor, T1b>1cm but 2cm).
T2: >2cm but 4cm tumor limited to thyroid gland.
T3: >4 cm tumor or gross extrathyroidal extension invading strap muscles only (T3a > 4 cm tumor limited to thyroid, T3b gross extrathyroidal extension invading only strap muscles of any size).
T4: includes gross extrathyroidal extension (T4a invades subcutaneous soft tissue, larynx, trachea, esophagus, or recurrent laryngeal nerve; T4b invades prevertebral fascia or encasing carotid or mediastinal vessels).
Management
– Thyroid lobectomy alone may be sufcient
treatment for small (<1cm), low-risk, unifo­cal, intrathyroidal papillary carcinomas.
– Gross disease (diameter over 1.0 cm)—total
thyroidectomy, and central compartment
lymph node removal is the therapy of choice.
– Central compartment neck dissection for
patients with nodal disease or in high-risk patients (advanced papillary thyroid carci­noma (T3–T4).
– Lateral neck dissection is indicated for biopsy-
proven metastatic lateral neck nodes.
Postoperative management
• For low-risk Well-Differentiated Thyroid Carcinoma (WDTC), radioactive iodine adju­vant therapy is not routinely recommended after thyroidectomy but should be considered in intermediate- and low-risk WDTC with other risk factors.
• Radioactive iodine adjuvant therapy is usually recommended after total thyroidectomy for high-risk WDTC.
Patient is considered high risk if any of the
following present [27]:
• Macroscopic tumor invasion.
• Incomplete tumor resection with gross resid­ual disease.
• Distant metastases.
• Postoperative serum thyroglobulin suggestive of distant metastases.
• Pathologic N1 with any metastatic lymph node 3cm in largest dimension.
• Follicular thyroid cancer with extensive vas­cular invasion (>4 foci of vascular invasion).
Follow-up: thyroglobulin measurement and diagnostic radioactive iodine scanning 2–8 days after radioiodine treatment.
– Radioiodine scan is usually repeated
6–12months after treatment with 131-I in moderate- to high-risk patients and in lower-risk patients who have detectable Tg
380
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
H. Haidar et al.
levels during follow-up that are not declining.
Prognosis: 95% 5-year survival; poor prog­nostic indicators include tumors >1.5 cm or extracapsular spread (cervical metastases have increased cervical recurrence rates without affecting survival).
34.2.5.2 Follicular Carcinoma
The second most common thyroid carcinoma representing about 10% of thyroid cancers [28].
It is more common in female with median age
around the sixth decade.
Twenty to 50% spread hematogenously with
distant metastasis (lymphatic spread is rare).
Diagnosis: Requires open biopsy in order to distinguish adenoma from carcinoma.
Histopathology: It has a sub-stational mor­phologic overlap with the benign follicular adenoma. Typically, it shows unifocal neo­plastic follicular cells that is less distinct from malignant papillary cells; malignancy can be determined if extracapsular spread is noted.
Staging: is similar to that of PTC.
Treatment: Total thyroidectomy ± neck dis- section. Radioactive iodine adjuvant therapy is usually recommended after total thyroidec­tomy for high-risk WDTC (see papillary thy-
roid cancer).
Prognosis: 70–85% 5-year survival and reaches to about 20% with distant metastasis. Angioinvasion, extracapsular spread denotes worse prognosis.
34.2.5.3 Hurthle Cell Carcinoma
Occurs mostly in older patients (60s).
Can be considered a variant of follicular carci-
noma, oxyphilic cells noted.
Believed to be more aggressive in nature,
spread can occur via lymphatic or hematogenous pathways.
Distant metastasis can reach up to 30%, with
40% bone followed by 30% lung.
Management: While the staging is similar to
• that of the PTC, radiouptake is poor in such cancers; aggressive surgery is the mainstay in treatment.
Prognosis: about 50% 5-year survivals [29, 30].
34.2.5.4 Medullary Thyroid
Carcinoma
The third most common of all thyroid cancers (3%), it originates from the parafollicular cells (C cells), which produce the hormone calcitonin [31, 32].
• 25% of medullary thyroid cancer cases are
genetic in nature, caused by a mutation in the RET proto-oncogene and inherited as an auto-
somal dominant trait. This form is identied as familial medullary thyroid cancer (FMTC). When it coexists with tumors of the parathy­roid gland and medullary component of the adrenal glands (pheochromocytoma), it is called multiple endocrine neoplasia type 2 (MEN2).
• Surgical removal of the thyroid in children who carry the mutant gene is curative if the entire thyroid gland is removed at an early age, before there is spread of the tumor.
• The parathyroid tumors and pheochromocyto­mas are removed when they cause clinical symptomatology.
• 75% of medullary thyroid carcinoma occurs in
“sporadic” fashion.
Markers: Calcitonin is useful as a marker
which can be tested in blood for detecting the presence of a tumor, and is an indicator of tumor mass.
Treatment: A plasma level of metanephrines
should be checked before surgical thyroidectomy to evaluate for the presence of pheochromocy-
toma as 25% of people found to have medullary
thyroid cancer and have the inherited form of the
MEN2A syndrome. Undiagnosed pheochromo-
cytoma leads to a very high intraoperative risk of hypertensive crisis and, potentially, death.
AL GRAWANY